| 发明名称 |
Method for Diagnosing Scleroderma |
| 摘要 |
The present invention relates to an in vitro method for diagnosing scleroderma in a subject, said method comprising the step of detecting in a biological sample obtained from the subject one or more autoantibodies recognizing one or more protein biomarkers selected from the group of proteins consisting of THEX1, AIF1, FGF2, EphB2, CLK1 and ANKS6. |
| 申请公布号 |
US2015185226(A1) |
申请公布日期 |
2015.07.02 |
| 申请号 |
US201314416334 |
申请日期 |
2013.07.23 |
| 申请人 |
INSERM (Institut National de la Sante et la Recherche Medicale) ;Assistance Publique-Hôpitaux de Marseille ;Université d'Aix Marseille |
发明人 |
Lambert Nathalie;Auger Isabelle;Roudier Jean |
| 分类号 |
G01N33/68 |
主分类号 |
G01N33/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An in vitro method for diagnosing scleroderma in a subject, said method comprising the step of detecting in a biological sample obtained from the subject one or more autoantibodies recognizing one or more protein biomarkers selected from the group of proteins consisting of THEX1, AIF1, FGF2, EphB2, CLK1 and ANKS6. |
| 地址 |
Paris FR |
